Skip to main content
. 2020 Sep 19;22(12):1367–1372. doi: 10.1016/j.jmoldx.2020.09.004

Table 2.

Summary of LOD Results

Molecular assay Target No. of replicates detected/total no. of replicates at each dilution expressed by GE/mL (% positive rate)
Probit (±95% CI), GE/mL Final LOD, GE/mL
4000 2000 1000 500 250 125
NWHL LDT S 4/4 6/6 (100) 9/10 (90) 5/10 (50) 2/8 (25) 1/8 (25) 1301 ± 13 1301 ± 13
Modified CDC assay N1 4/4 6/6 (100) 9/10 (90) 7/10 (70) 6/8 (75) 1/8 (25) 1249 ± 14 1249 ± 14
N2 4/4 6/6 (100) 10/10 (100) 5/10 (50) 2/8 (25) 1/8 (25) 946 ± 11

GE/mL, genome equivalents/mL; LOD, limit of detection; NWHL LDT, Northwell Health Laboratories laboratory-developed test.

Upper/lower (±) 95% CI.

The final LODs were based on both assays’ results interpretation algorithm and determined by using probit analysis.